However, ProBNP elevation in COVID-19 patients may indicate myocardium tissue injury and inflammation, or its increase is due to hypoxia-induced pulmonary hypertension resulting an injury to the myocardium wall and therefore increasing the release of ProBNP. This evidence concerns the gene NPPB and pulmonary arterial hypertension.